The U.S. has entered a new phase in its COVID-19 vaccination campaign, with shots now available to millions of elementary-age children. The vaccine — one-third the dose for teens and adults — requires two shots three weeks apart.
The actions mean sleepovers, playdates and family get-togethers put off for more than a year will be back on the agenda for many kids, along with a chance for fewer school interruptions.
“This is a big milestone for 5- to 11-year-olds because they make up nearly 40% of children under 18,” said Dr. Jennifer Shu, a Decatur, Georgia, pediatrician, who received her first shipment Tuesday morning. Many locations planned mass vaccination events in coming days. And while many pediatricians’ offices were expecting strong demand at least initially, almost two-thirds of parents recently polled by the Kaiser Family Foundation said they would either wait or not seek out the vaccines for their kids.
Government authorities said pediatricians and family doctors, whom parents depend on to give routine childhood vaccinations, could help build trust. A Pfizer study of 2,268 children found the vaccine was almost 91% effective at preventing symptomatic COVID-19 infections. The FDA examined 3,100 vaccinated kids in concluding the shots are safe.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Long Covid: What to Know About Lingering Symptoms of a Covid-19 InfectionWhat causes long Covid? Are certain people more susceptible to getting it? What’s the deal with long Covid and brain fog? Here’s what the latest research, as well as doctors and patients, say about the condition.
Les mer »
CDC panel weighs risks and benefits of COVID-19 vaccine for young childrenCDC’s advisors are weighing who will get the most benefit as they deliberate whether to recommend the shots for up to 28 million more children, or perhaps only for those most vulnerable to serious illness.
Les mer »
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 blnPfizer Inc on Tuesday said it expected this year to sell $36 billion of the COVID-19 vaccine it developed with German partner BioNTech and forecast another $29 billion in sales in 2022, topping analyst estimates for both years.
Les mer »
Kids and the COVID-19 vaccine: 5 questions answered by pediatriciansThe nation's top health experts have said that getting more kids vaccinated will be key to managing the pandemic in the U.S.
Les mer »
CDC Recommends COVID-19 Vaccine for Younger ChildrenThe expert panel decided the benefits of getting vaccinated outweighed the risks for children ages 5 to 11 years
Les mer »
Analysis: Country by country, scientists eye beginning of an end to the COVID-19 pandemicAs the devastating Delta variant surge eases in many regions of the world, scientists are charting when, and where, COVID-19 will transition to an endemic disease in 2022 and beyond, according to Reuters interviews with over a dozen leading disease experts.
Les mer »